Most just lately, it has been determined that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in comparable regions as classical opioid receptors, it binds to the wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts like a scavenger and does not activate a 2nd mess